Systemic sclerosis - associated interstitial lung disease – proposed recommendations for future randomised clinical trials

1Division of Rheumatology, 2Biomathematics, 3Pulmonary and Critical Care, Department of Medicine, and 4Department of Radiology, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA; 5Department of Medicine, National Jewish Health, Denver, CO, USA; 6Division of Rheumatology, University of Connecticut Health Center, Farmington, CT, USA; 7Division of Rheumatology, Medical University of South Carolina, Charleston, SC, USA; 8Royal Brompton Hospital and National Heart and Lung Institute, London, U.K. Authorship arranged alphabetically (except for first author). Dinesh Khanna, MD, MS Kevin K. Brown, MD Philip J, Clements, MD, MPH Robert Elashoff, PhD Daniel E. Furst, MD Jonathan Goldin, MD, PhD James R. Seibold, MD Richard M. Silver, MD Donald P. Tashkin, MD Athol U. Wells, MD Please address correspondence to: Dinesh Khanna, MD, MS, David Geffen School of Medicine at UCLA, 90095 Los Angeles, CA, USA. E-mail: [email protected] Received on May 10, 2010; accepted on May 11, 2010. Clin Exp Rheumatol 2010: 28 (Suppl. 58): S55-S62. © Copyright CLINICAL AND EXPERIMENTAL RHEUMATOLOGY 2010.